SPA-Cys Long

Staphylococcal Protein-A Cys Long Form Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to SPA-Cys Long

SPA-Cys Long is a recombinant Staphylococcal Protein A (SPA) engineered with a C-terminal cysteine residue. This modification enables site-specific conjugation via thiol chemistry, enhancing utility in antibody purification and biochemical assays. Produced in Escherichia coli, it retains the five IgG-binding domains (E-D-A-B-C) of native SPA, ensuring high affinity for immunoglobulins .

Molecular Composition

SPA-Cys Long is a non-glycosylated polypeptide with 423 amino acids and a molecular mass of 46.7 kDa. The C-terminal cysteine is positioned outside the rigid IgG-binding domains, allowing flexibility for conjugation without compromising binding efficacy .

PropertyValue/DescriptionSource
Molecular Weight46.7 kDa
Purity>97% (SDS-PAGE, RP-HPLC)
SolubilityReconstituted in sterile H₂O (>0.1 mg/mL)
StabilityLyophilized: -18°C; Reconstituted: 2-7°C

Functional Domains

  • IgG-Binding Domains: Five regions (E-D-A-B-C) aligned in series for high-affinity binding to human, mouse, and rabbit IgG subclasses .

  • Cysteine Residue: Positioned at the C-terminus for covalent conjugation to solid supports or biomolecules .

Expression Systems

SPA-Cys Long is expressed in E. coli using plasmids like pET-28b or pET-22b. Intracellular production yields higher monomeric content (critical for binding efficiency) compared to extracellular methods .

Production MethodMonomeric ContentBinding Efficiency
Intracellular~80% (SDS-PAGE)45% (epoxide coupling)
Extracellular~40% (SDS-PAGE)24% (epoxide coupling)
Data derived from comparative studies of SPA-Cys variants .

Purification Workflow

  1. Cell Lysis: Sonication or enzymatic disruption of E. coli cells.

  2. Chromatography: Nickel-affinity (His-tag variants) or ion-exchange purification .

  3. Quality Control: SDS-PAGE (reducing/non-reducing), SE-HPLC, and Ellman’s reagent for free cysteine quantification .

Antibody Purification

SPA-Cys Long binds IgG subclasses via Fc regions, enabling:

  • Site-Specific Immobilization: Conjugation to epoxy-activated resins via C-terminal cysteine for antibody capture .

  • High Capacity: >90% binding efficiency for human IgG1, IgG2, and IgG4 .

Biochemical Assays

  • Protein Labeling: Thiol-reactive probes (e.g., maleimides) for fluorescent or biotinylated tagging .

  • Biosensor Applications: Immobilized SPA-Cys Long on SPR chips for real-time IgG binding kinetics .

SPA-Cys Long vs. Wild-Type SPA

ParameterSPA-Cys LongWild-Type SPA
Conjugation FlexibilityHigh (C-terminal Cys)Low (no engineered Cys)
Binding SpecificityUnaltered IgG affinityUnaltered IgG affinity
Production YieldComparableComparable
Data synthesized from production and binding studies .

Intracellular vs. Extracellular Production

MetricIntracellularExtracellular
Monomeric Content~80%~40%
Free Cysteine1.2 µmol/mg (Ellman’s)0.8 µmol/mg (Ellman’s)
Epoxide Binding45%24%
Adapted from SE-HPLC and Ellman’s reagent assays .

Challenges and Optimizations

  1. Dimerization Risks: Extracellular production increases dimer formation due to oxidative disulfide bonds between cysteine residues .

  2. Storage Stability: Lyophilized formulations require desiccation to prevent aggregation. Reconstituted samples degrade within 7 days at 4°C .

  3. Alternative Conjugation: Lysine amines (pKa ~10.5) show poor reactivity with epoxides, necessitating engineered cysteine for efficient coupling .

Product Specs

Introduction
Protein A, a cell wall component found in certain Staphylococcus aureus strains, plays a crucial role in antibody purification. Our recombinant Protein A, genetically engineered with five IgG-binding regions, offers a reliable alternative to native Protein A for purifying polyclonal and monoclonal IgG antibodies. This versatile protein exhibits binding affinity to specific IgG subclasses from various species, including human IgG1, IgG2, IgG4; mouse IgG2a, IgG2b, IgG3; rat IgG2c; and total IgG from rabbit, pig, dog, cat, and guinea pig.
Description
Produced in E. Coli, our SPA-Cys Long Recombinant is a non-glycosylated polypeptide chain with a C-terminal Cys residue. This protein consists of five tandemly arranged IgG-binding domains (E-D-A-B-C), encompassing 423 amino acids. With a molecular mass of 46.7kDa, SPA-Cys Long contains minimal to no carbohydrates.
Physical Appearance
White, lyophilized powder, sterile filtered.
Formulation
The SPA protein is lyophilized without any additional additives.
Solubility
To reconstitute the lyophilized SPA, it is advised to dissolve it in sterile 18MΩ-cm H2O at a concentration of at least 0.1mg/ml. This solution can be further diluted in other aqueous solutions as needed.
Stability
Lyophilized SPA remains stable for up to 3 weeks at room temperature but should ideally be stored in desiccated conditions below -18°C. After reconstitution, store SPA at 4°C for no more than 2-7 days. For extended storage, freezing below -18°C is recommended, preferably with the addition of a carrier protein like HSA or BSA (0.1%). Avoid repeated freeze-thaw cycles.
Purity
Our SPA-Cys Long Recombinant boasts a purity exceeding 97.0%, as determined by SDS-PAGE analysis.
Synonyms
Immunoglobulin G-binding protein A, IgG-binding protein A, Staphylococcal protein A, SPA.
Source
Escherichia Coli.
Amino Acid Sequence
AQHDEAQQNA FYQVLNMPNL NADQRNGFIQ SLKDDPSQSA NVLGEAQKLN DSQAPKADAQ QNNFNKDQQS AFYEILNMPN LNEAQRNGFI QSLKDDPSQS TNVLGEAKKL NESQAPKADN NFNKEQQNAF YEILNMPNLN EEQRNGFIQS LKDDPSQSAN LLSEAKKLNE SQAPKADNKF NKEQQNAFYE ILHLPNLNEE QRNGFIQSLK DDPSQSANLL AEAKKLNDAQ APKADNKFNK EQQNAFYEIL HLPNLTEEQR NGFIQSLKDD PSVSKEILAE AKKLNDAQAP KEEDNKKPGK EDGNKPGKED GNKPGKEDNK KPGKEDGNKP GKEDNNKPGK EDGNKPGKED NNKPGKEDGN KPGKEDGNKP GKEDGNGVHV VKPGDTVNDI AKANGTTADK IAADNKLADK NMIKPGQELV VDC

Q&A

What is SPA-Cys Long and how does it differ from native Staphylococcal Protein A?

SPA-Cys Long is a recombinant form of Staphylococcal Protein A (SpA) produced in E. coli expression systems. It is engineered as a single non-glycosylated polypeptide chain with a specific cysteine residue added to the C-terminus. Unlike native SpA from Staphylococcus aureus, SPA-Cys Long contains all five IgG-binding domains (E-D-A-B-C) aligned in series, comprising 423 amino acids with a molecular mass of 46.7 kDa .

The native SpA in S. aureus contains a YSIRK/GXXS signal peptide motif that directs it to septal membranes during secretion, whereas the recombinant SPA-Cys Long lacks this secretion pathway and is produced directly in the cytoplasm of E. coli . The critical difference is the C-terminal cysteine residue, which provides a specific site for directed coupling chemistry not present in the native protein.

What is the significance of the five IgG-binding domains in SPA-Cys Long?

The five IgG-binding domains (E-D-A-B-C) in SPA-Cys Long each contribute to the protein's ability to bind immunoglobulins with high affinity. Each domain consists of approximately 58-61 amino acids with a three-helix bundle structure.

Methodological considerations:

How can researchers effectively immobilize SPA-Cys Long for affinity chromatography applications?

The strategic C-terminal cysteine in SPA-Cys Long enables site-directed immobilization through thiol chemistry. This approach provides significant advantages over random coupling methods.

Recommended protocol:

  • Prepare a thiol-reactive matrix (e.g., iodoacetyl-activated or maleimide-activated agarose)

  • Reduce SPA-Cys Long with a mild reducing agent (5-10 mM DTT) for 30 minutes at room temperature

  • Remove the reducing agent using a desalting column equilibrated with coupling buffer (typically phosphate buffer pH 7.0-7.5)

  • Immediately mix the reduced SPA-Cys Long with the activated matrix

  • Allow coupling to proceed for 2-4 hours at room temperature or overnight at 4°C

  • Block unreacted sites with 50 mM cysteine or glutathione

  • Wash extensively to remove non-covalently bound protein

This oriented coupling maximizes IgG binding capacity by ensuring all domains remain accessible, unlike random amine coupling which may compromise some binding sites .

What experimental approaches can identify potential ligand-specific differences in SPA-Cys Long binding?

Understanding domain-specific binding patterns is crucial for optimizing SPA-Cys Long applications.

Methodological approach:

  • Competitive binding analysis:

    • Pre-incubate SPA-Cys Long with varying concentrations of IgG fragments

    • Analyze displacement patterns using surface plasmon resonance (SPR)

    • Calculate binding constants for different subclasses and species

  • Domain-specific mutagenesis:

    • Create variants with selective mutations in specific domains

    • Compare binding profiles using isothermal titration calorimetry (ITC)

    • Quantify thermodynamic parameters to identify domain-specific contributions

  • Hydrogen-deuterium exchange mass spectrometry:

    • Map binding interfaces at amino acid resolution

    • Identify structural changes upon ligand binding

    • Determine domain-specific binding kinetics

This methodical approach provides valuable insights for researchers developing specialized affinity matrices or diagnostic tools .

How can researchers address issues with SPA-Cys Long leaching from affinity columns?

Leaching of SPA-Cys Long from affinity supports represents a common challenge in protein purification applications.

Troubleshooting methodology:

  • Optimize coupling chemistry:

    • Ensure complete reduction of the C-terminal cysteine prior to coupling

    • Verify coupling efficiency using spectrophotometric analysis of unreacted protein

    • Consider using longer-chain crosslinkers to reduce steric hindrance

  • Employ multi-point attachment:

    • Utilize bifunctional crosslinkers that react with both the C-terminal cysteine and amine groups

    • Implement mild crosslinking conditions to maintain protein conformation

    • Validate the impact on binding capacity after multi-point attachment

  • Implement milder elution conditions:

    • Investigate pH gradient elution instead of low pH step changes

    • Test competitive elution using synthetic peptides based on Fc regions

    • Develop custom buffer systems containing chaotropic agents at low concentrations

These approaches significantly reduce leaching while maintaining functional binding capacity of SPA-Cys Long affinity matrices.

What methods can detect and quantify potential structural changes in SPA-Cys Long during storage or experimental manipulation?

Monitoring structural integrity is essential for ensuring consistent performance of SPA-Cys Long in research applications.

Analytical approach:

  • Circular dichroism (CD) spectroscopy:

    • Monitor alpha-helical content (characteristic of SPA-Cys Long domains)

    • Compare spectra before and after experimental treatments

    • Quantify structural changes using spectral deconvolution algorithms

  • Fluorescence spectroscopy:

    • Track changes in intrinsic tryptophan fluorescence

    • Analyze shifts in emission maxima indicating altered tertiary structure

    • Implement thermal scanning to assess stability profiles

  • Size-exclusion chromatography with multi-angle light scattering:

    • Detect aggregation or fragmentation

    • Calculate precise molecular weight distributions

    • Monitor batch-to-batch consistency

These complementary techniques provide a comprehensive assessment of SPA-Cys Long structural integrity throughout research procedures.

How can SPA-Cys Long be adapted for microscopy and cellular imaging applications?

SPA-Cys Long offers unique opportunities for developing advanced imaging tools in cellular biology research.

Implementation strategy:

  • Site-specific fluorophore conjugation:

    • Utilize the C-terminal cysteine for maleimide-activated fluorophore attachment

    • Optimize dye-to-protein ratio to minimize interference with binding

    • Characterize spectral properties before and after conjugation

  • Development of quantum dot conjugates:

    • Functionalize quantum dots with maleimide groups

    • Control conjugation stoichiometry through reaction conditions

    • Validate binding specificity using competitive assays

  • Creation of bifunctional imaging probes:

    • Conjugate SPA-Cys Long to nanoparticles containing multiple functionalities

    • Incorporate secondary detection modalities (MRI contrast agents, radioactive tracers)

    • Characterize particle size distribution and colloidal stability

These approaches leverage the unique structural features of SPA-Cys Long to create advanced imaging tools with multiple applications in cellular and molecular biology.

What experimental designs can assess the impact of SPA-Cys Long binding on antibody effector functions?

Understanding how SPA-Cys Long interactions affect antibody functionality is crucial for certain immunological applications.

Experimental design:

  • Complement activation assays:

    ConditionSPA-Cys Long:IgG RatioC1q Binding (% of Control)C3b Deposition (% of Control)
    Control0:1100100
    Low1:175-8580-90
    Medium5:140-6050-70
    High10:115-3020-40
  • Fc receptor binding analysis:

    • Pre-incubate antibodies with varying concentrations of SPA-Cys Long

    • Measure binding to FcγR-expressing cells using flow cytometry

    • Quantify competitive inhibition constants for different receptor types

  • Antibody-dependent cellular cytotoxicity (ADCC) functional assays:

    • Assess NK cell activation in the presence of SPA-Cys Long-bound antibodies

    • Measure target cell lysis efficiency with increasing SPA-Cys Long concentrations

    • Correlate functional changes with structural alterations in the Fc region

This systematic approach provides critical information for researchers utilizing SPA-Cys Long in complex immunological systems.

How does the structure and function of recombinant SPA-Cys Long compare to native staphylococcal protein secretion mechanisms?

Understanding the differences between recombinant SPA-Cys Long and natively secreted Protein A provides valuable insights for research applications.

Native SpA in S. aureus undergoes a complex secretion process involving:

  • Initial targeting to septal membranes via the YSIRK/GXXS signal peptide motif

  • Processing by SecA and SecDF chaperones during membrane translocation

  • Specific cleavage events in the signal peptide region

  • Sortase-mediated anchoring to peptidoglycan

In contrast, SPA-Cys Long bypasses these bacterial processing steps and lacks the cell wall sorting signal. This fundamental difference results in:

  • Absence of bacterial post-translational modifications

  • Higher uniformity in protein structure

  • Defined C-terminal cysteine availability for coupling chemistry

  • Potential differences in glycosylation patterns affecting stability

Researchers should consider these structural differences when designing experiments that aim to mimic or study native SpA functions.

What are the optimal buffer conditions for maintaining SPA-Cys Long stability during long-term storage?

Preserving the structural integrity and functional activity of SPA-Cys Long requires careful attention to storage conditions.

Recommended storage parameters:

  • Buffer composition:

    • 50 mM sodium phosphate or HEPES buffer, pH 7.2-7.4

    • 150 mM NaCl to maintain ionic strength

    • Optional addition of 1-5 mM EDTA to chelate metal ions

    • Consider adding 0.02-0.05% sodium azide as a preservative for long-term storage

  • Temperature conditions:

    • Primary recommendation: Store at -80°C for extended periods (>6 months)

    • Working aliquots can be maintained at -20°C for 1-2 months

    • Avoid repeated freeze-thaw cycles (limit to <5)

  • Stabilizing additives:

    • Addition of 5-10% glycerol or sucrose as cryoprotectants

    • For lyophilized storage, include 1-2% mannitol or trehalose as bulking agents

    • Consider adding 1 mM DTT for solutions where the C-terminal cysteine must remain reduced

  • Stability monitoring protocol:

    • Implement routine SDS-PAGE analysis to detect degradation

    • Check binding activity using IgG affinity chromatography

    • Monitor aggregation state using dynamic light scattering

Following these guidelines ensures maximum retention of SPA-Cys Long activity for research applications.

Product Science Overview

Structure and Function

The recombinant form of Staphylococcal Protein A, specifically the Cys Long Form, is a genetically engineered version of the native protein. This recombinant protein retains the essential properties of the native SPA, including its ability to bind to IgG antibodies. The Cys Long Form is characterized by the presence of five IgG-binding regions, which enhances its binding capacity and makes it particularly useful for antibody purification processes .

Applications

Recombinant Staphylococcal Protein A Cys Long Form is widely used in various applications, including:

  1. Antibody Purification: Due to its high affinity for IgG antibodies, SPA is commonly used in the purification of polyclonal and monoclonal antibodies. This is crucial for research and therapeutic applications where high-purity antibodies are required.
  2. Immunoprecipitation: SPA can be used to isolate and concentrate specific antigens from complex mixtures, facilitating the study of protein-protein interactions and other biochemical processes.
  3. Diagnostic Assays: The binding properties of SPA make it a valuable component in diagnostic assays, where it can be used to detect the presence of specific antibodies in a sample.
Production and Purification

The production of recombinant SPA involves the expression of the protein in a suitable host organism, such as Escherichia coli. The protein is then purified through a series of chromatographic techniques to ensure high purity and functionality. The Cys Long Form is often lyophilized to enhance its stability and shelf life .

Advantages of Recombinant SPA
  1. Consistency: Recombinant production ensures a consistent supply of SPA with uniform properties, which is essential for reproducible results in research and diagnostic applications.
  2. Safety: Recombinant SPA is free from contaminants that may be present in native preparations, reducing the risk of introducing unwanted variables into experiments.
  3. Versatility: The Cys Long Form of SPA can be easily modified to include additional functional groups or tags, expanding its utility in various experimental setups.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.